Dhruv Kumar

Dhruv Kumar


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2024 in Biosensors
Verified
Journal Article
Open access
PDF file
DRDivakar Raj
Divakar Raj
AKArun Kumar
Arun Kumar
DKDhruv Kumar
Dhruv Kumar
Krishna KantKrishna Kant
Krishna Kant
Ashish MathurAshish Mathur
Ashish Mathur
Prostate cancer is one of the most prevalent cancers afflicting men worldwide, often detected at advanced stages, leading to increased mortality rates. Addressing this challenge, we present an innovative approach employing electrochemical biosensing for early-stage prostate cancer detection. This study used Indium–Tin Oxide (ITO) as a substrate and a deposited gold–graphene quantum dot (Au–GQD) nanohybrid to establish electrochemical sensing platforms for DNA-hybridization assays. A capturing DNA probe, PCA3, was covalently immobilized on the surface of the Au–GQDs and deposited electrochemically onto the ITO electrode surface. The Au–GQDs enabled the capturing of the target PCA3 biomarker probe. The sensor achieved a limit of detection (LoD) of up to 211 fM and presented a linear detection range spanning 1 µM to 100 fM. A rapid 5-min response time was also achieved. The tested shelf life of the pre-immobilized sensor was approximately 19 ± 1 days, with pronounced selectivity for its intended target amidst various interferants. The sensing device has the potential to revolutionize prostate cancer management by facilitating early-stage detection and screening with enhanced treatment efficacy.

4 September 2023 in Cancers
Verified
Journal Article
Open access
PDF file
SASaniya Arfin
Saniya Arfin
DKDhruv Kumar
Dhruv Kumar
ALAndrea Lomagno
Andrea Lomagno
PIETROLUIGI MAURIPIETROLUIGI MAURI
PIETROLUIGI MAURI
Dario Di SilvestreDario Di Silvestre
Dario Di Silvestre
Head and neck squamous cell carcinoma (HNSCC) is among the most common cancer worldwide, accounting for hundreds thousands deaths annually. Unfortunately, most patients are diagnosed in an advanced stage and only a percentage respond favorably to therapies. To help fill this gap, we hereby propose a retrospective in silico study to shed light on gene–miRNA interactions driving the development of HNSCC. Moreover, to identify topological biomarkers as a source for designing new drugs. To achieve this, gene and miRNA profiles from patients and controls are holistically reevaluated using protein–protein interaction (PPI) and bipartite miRNA–target networks. Cytoskeletal remodeling, extracellular matrix (ECM), immune system, proteolysis, and energy metabolism have emerged as major functional modules involved in the pathogenesis of HNSCC. Of note, the landscape of our findings depicts a concerted molecular action in activating genes promoting cell cycle and proliferation, and inactivating those suppressive. In this scenario, genes, including VEGFA, EMP1, PPL, KRAS, MET, TP53, MMPs and HOXs, and miRNAs, including mir-6728 and mir-99a, emerge as key players in the molecular interactions driving HNSCC tumorigenesis. Despite the heterogeneity characterizing these HNSCC subtypes, and the limitations of a study pointing to relationships that could be context dependent, the overlap with previously published studies is encouraging. Hence, it supports further investigation for key molecules, both those already and not correlated to HNSCC.

9 March 2023
Verified
Book Chapter
Closed access
SRSibi Raj
Sibi Raj
DKDhruv Kumar
Dhruv Kumar

1 November 2024 in Chemical Biology Letters
Verified
Journal Article
Open access
PDF file
PPP. Priya
P. Priya
AKArun Kumar
Arun Kumar
Ashok GhoshAshok Ghosh
Ashok Ghosh
RCRicha Chauhan
Richa Chauhan
RKRanjit Kumar
Ranjit Kumar
DKDhruv Kumar
Dhruv Kumar
Breast cancer remains a leading cause of cancer-related morbidity and mortality among women globally. Breast cancer is the most diagnosed cancer in women. Metastasis is the primary cause of mortality for breast cancer patients. In Bihar, there are so many cases of Breast Cancer patients found but most of them collected near the Gangetic plane. Also, we compared the real data of Breast cancer patients from the data available on TCGA. We performed comparison of the trend of ER, PR, and HER-2 expression trend in both data. This research has highlighted the significant role of inflammatory cytokines in the tumor microenvironment, particularly tumor necrosis factor-α (TNF-α), Interleukin-6 (IL-6), and Interleukin-1 beta (IL-1β). These cytokines are implicated in various stages of breast cancer development, including tumor initiation, progression, and metastasis. TNF-α helps to promote tumor growth through enhancing processes such as angiogenesis and inhibition of apoptosis. IL-6 and IL-1β contribute to cancer cell proliferation, survival, and resistance to therapy by activating key signaling pathways like the JAK/STAT pathway. This research reveals the roles of TNF-α, IL-6, and IL-1β in breast cancer, and sheds light on how they affect the tumor microenvironment and the course of the illness. These cytokines contribute to breast cancer progression and may help to produce targeted therapy and open up new options for individualized treatment plans

27 April 2025
Verified
Book Chapter
Closed access
PDF file
MSMohd Saad
Mohd Saad
DKDhruv Kumar
Dhruv Kumar

1 May 2026
Verified
Book Chapter
Closed access
PDF file
GSGayatri Shamsunder Salgaonkar
Gayatri Shamsunder Salgaonkar
DDDishita Dutta
Dishita Dutta
VSVinayak Shishodia
Vinayak Shishodia
DKDhruv Kumar
Dhruv Kumar